Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of Medicinal Chemistry

Temozolomide-Derived Therapeutic Strategies to Overcome Resistance in Glioblastoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HZH. ZhangYLYupeng Li

Discussion

Loading...

Member takes

Overview

This perspective reviews temozolomide-based therapies and highlights clinical outcomes in glioblastoma, suggesting new avenues for treatment.

Key Points

  • Temozolomide-based regimens show potential in enhancing treatment efficacy for glioblastoma patients.
  • Over 50% of glioblastoma patients have unmethylated MGMT promoters that lower TMZ effectiveness.
  • Research is focusing on modifying TMZ, creating hybrids, and rational combinations to counteract glioblastoma resistance.
  • Advancements in drug development and the integration of immunotherapies may significantly improve outcomes for GBM.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68c23caeb210217d6478a94chttps://doi.org/10.1021/acs.jmedchem.5c02019
View Full Paper
Ask AI
Bookmark
Share